ANI PHARMACEUTICALS INC. - COMMON STOCK

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

19 2月 2025 13:30:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

18 2月 2025 13:05:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

28 1月 2025 13:30:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

13 1月 2025 03:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

02 1月 2025 03:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

30 12月 2024 13:05:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

26 11月 2024 13:30:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

08 11月 2024 03:50:28 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

04 11月 2024 13:30:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

30 10月 2024 14:00:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

25 10月 2024 03:50:54 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

24 10月 2024 03:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

26 9月 2024 03:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

16 9月 2024 05:53:27 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

16 9月 2024 03:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

13 9月 2024 03:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

11 9月 2024 03:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

10 9月 2024 11:09:55 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes

13 8月 2024 13:05:27 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

07 8月 2024 18:44:18 条件 Nasdaq GlobeNewswire